A powerful GABA(B) receptor-mediated inhibition of GABAergic neurons in the arcuate nucleus

NeuroReport

Volumn 9, Issue 18, 1998, Pages 4171-4177

  Wagner, Edward J ^a   Bosch, Martha A ^a   Kelly, Martin J ^a   Ronnekleiv K ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Division of Neuroscience   (United States)

Author keywords

Arcuate nucleus; Electrophysiology; GABA; Glutamatic acid decarboxylase; In situ hybridization; Potassium conductance

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; GLUTAMATE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; GABAERGIC TRANSMISSION; GUINEA PIG; HORMONE RELEASE; HYPERPOLARIZATION; IN SITU HYBRIDIZATION; MEMBRANE DEPOLARIZATION; NONHUMAN; POSTSYNAPTIC INHIBITION; POTASSIUM CONDUCTANCE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL;

EID: 0032556678     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199812210-00032     Document Type: Article

References (25)

1. Wojcik WJ and Holopainen I. Neuropsychopharmacology 6, 201-214 (1992).
2. Bowery NG. Annu Rev Pharmacol Toxicol 33, 109-147 (1993).
3. Kerr DIB and Ong J. Pharmacol Ther 67, 187-246 (1995).
4. Kaupmann K, Huggel K, Heid J et al. Nature 386, 239-246 (1997).
5. Loose MD, Ronnekleiv OK and Kelly MJ. Neuroendocrinology 54, 537-544 (1991).
6. Wagner EJ, Goudreau JL, Moore KE and Lookingland KJ. Brain Res 659, 194-200 (1994).
7. Lagrange AH, Ronnekleiv OK and Kelly MJ. Endocrinology 136, 2341-2344 (1995).
8. Tappaz ML, Brownstein MJ and Kopin IJ. Brain Res 125, 109-121 (1977).
9. Decavel C and van den Pol AN. J Comp Neurol 316, 104-116 (1992).
10. Anderson R and Mitchell R. Eur J Pharmacol 115, 109-112 (1985).
11. Locatelli V, Cocchi D, Racagni G et al. Brain Res 145, 173-179 (1978).
12. Anderson R and Mitchell R. Eur J Pharmacol 124, 1-9 (1986).
13. Párducz A, Perez J and Garcia-Segura LM. Neuroscience 53, 395-401 (1993).
14. Olpe HR, Karlsson G, Pozza MF et al. Eur J Pharmacol 187, 27-38 (1990).
15. Lagrange AH, Wagner EJ, Ronnekleiv OK and Kelly MJ. Neuroendocrinology 64, 114-123 (1996).
16. Ronnekleiv OK, Bosch MA, Naylor BR and Kelly MJ. Methods Neurosci 5, 85-108 (1991).
17. Bunzow J R, Zhang G, Bouvier C et al. J Neurochem 64, 14-24 (1995).
18. Newberry NR and Nicoll RA. Nature 308, 450-452 (1984).
19. Pitler TA and Alger BE. J Neurophysiol 72, 2317-2327 (1994).
20. Beck SG. Birnstiel S, Pouliot WA and Choi KC. NeuroReport 6, 310-312 (1995).
21. Williams JT, Colmers WF and Pan ZZ. J Neurosci 8, 3499-3506 (1988).
22. Seabrook GR, Howson W and Lacey MG. Br J Pharmacol 101, 949-957 (1990).
23. Bon C and Galvan M. Br J Pharmacol 118, 961-967 (1996).
24. Bonanno G and Raiteri M. Trends Pharmacol Sci 14, 259-261 (1993).
25. Ansonoff MA and Etgen AM. Endocrinology 139, 3050-3056 (1998).